CorMedix (CRMD) News Today $7.16 -0.18 (-2.45%) Closing price 03/26/2025 04:00 PM EasternExtended Trading$7.12 -0.04 (-0.49%) As of 03/26/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period CorMedix (NASDAQ:CRMD) Shares Gap Down - Here's What HappenedCorMedix (NASDAQ:CRMD) Shares Gap Down - Here's WhyMarch 26 at 4:48 PM | marketbeat.comTraders Buy Large Volume of Call Options on CorMedix (NASDAQ:CRMD)CorMedix Inc. (NASDAQ:CRMD - Get Free Report) saw unusually large options trading activity on Tuesday. Stock investors bought 4,076 call options on the company. This is an increase of approximately 170% compared to the average daily volume of 1,508 call options.March 26 at 11:49 AM | marketbeat.comCorMedix's (CRMD) Buy Rating Reaffirmed at D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $15.00 price target on shares of CorMedix in a report on Tuesday.March 26 at 9:14 AM | marketbeat.comCorMedix (NASDAQ:CRMD) Issues Earnings Results, Beats Estimates By $0.17 EPSCorMedix (NASDAQ:CRMD - Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.17. The firm had revenue of $30.00 million for the quarter, compared to the consensus estimate of $27.46 million. CorMedix's quarterly revenue was up 29900.0% compared to the same quarter last year.March 26 at 8:48 AM | marketbeat.comCorMedix (NASDAQ:CRMD) Posts Earnings Results, Beats Expectations By $0.17 EPSCorMedix (NASDAQ:CRMD - Get Free Report) released its earnings results on Tuesday. The company reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.17. The business had revenue of $30.00 million during the quarter, compared to the consensus estimate of $27.46 million. The firm's quarterly revenue was up 29900.0% compared to the same quarter last year.March 26 at 8:24 AM | marketbeat.comCormedix Inc (CRMD) Q4 2024: Everything You Need To Know Ahead Of EarningsMarch 26 at 12:24 AM | finance.yahoo.comCorMedix Inc. Achieves Profitability with DefenCath LaunchMarch 26 at 12:03 AM | tipranks.comCorMedix Dives on ResultsMarch 25 at 7:24 PM | baystreet.caCorMedix Shares Plunge After 1H Guidance Missed ExpectationsMarch 25 at 7:24 PM | marketwatch.comCorMedix shares tumble after order delayMarch 25 at 7:24 PM | investing.comCorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It OffMarch 25 at 7:24 PM | msn.comCorMedix (CRMD) Q4 2024 Earnings Call TranscriptMarch 25 at 7:24 PM | msn.comINVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLCMarch 25 at 5:06 PM | globenewswire.comCorMedix Inc. (CRMD) Q4 2024 Earnings Call TranscriptMarch 25 at 11:01 AM | seekingalpha.comCorMedix Inc. Reports Q4 2024 Net Revenue of $31.2 Million and First Profitable Quarter in Company HistoryMarch 25 at 8:30 AM | quiverquant.comCorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 25 at 7:30 AM | globenewswire.comCorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallMarch 24 at 10:05 AM | benzinga.comCorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025March 18, 2025 | globenewswire.comComparing Lexicon Pharmaceuticals (NASDAQ:LXRX) and CorMedix (NASDAQ:CRMD)March 18, 2025 | americanbankingnews.comTruist Financial Remains a Buy on Cormedix (CRMD)March 17, 2025 | markets.businessinsider.comCorMedix (NASDAQ:CRMD) Shares Down 7.4% - Here's WhyCorMedix (NASDAQ:CRMD) Shares Down 7.4% - Here's What HappenedMarch 14, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Upgraded at Leerink PartnrsLeerink Partnrs raised shares of CorMedix to a "strong-buy" rating in a research note on Friday.March 9, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Shares Gap Up - Still a Buy?CorMedix (NASDAQ:CRMD) Shares Gap Up - Here's What HappenedMarch 8, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Coverage Initiated by Analysts at Leerink PartnersLeerink Partners initiated coverage on shares of CorMedix in a research report on Friday. They issued an "outperform" rating and a $18.00 price target on the stock.March 8, 2025 | marketbeat.comLeerink Partners Initiates Coverage of CorMedix (CRMD) with Outperform RecommendationMarch 8, 2025 | msn.comCorMedix initiated with an Outperform at LeerinkMarch 7, 2025 | markets.businessinsider.comCorMedix Inc. (NASDAQ:CRMD) Given Consensus Rating of "Buy" by BrokeragesCorMedix Inc. (NASDAQ:CRMD - Get Free Report) has received a consensus recommendation of "Buy" from the six analysts that are currently covering the company, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month target priceMarch 7, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Earns Buy Rating from D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $15.00 target price on shares of CorMedix in a research report on Wednesday.March 6, 2025 | marketbeat.comCorMedix (CRMD) Expected to Announce Earnings on TuesdayCorMedix (NASDAQ:CRMD) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports.March 4, 2025 | marketbeat.comNew York State Common Retirement Fund Grows Stock Position in CorMedix Inc. (NASDAQ:CRMD)New York State Common Retirement Fund boosted its position in CorMedix Inc. (NASDAQ:CRMD - Free Report) by 1,398.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 167,249 shares of the company's stock after purchasing an additional 156,086 shMarch 3, 2025 | marketbeat.com3 Value Stocks Backed by World’s Largest Activist Hedge FundFebruary 26, 2025 | investing.comCormedix (NASDAQ:CRMD) Stock Quotes, Forecast and News SummaryFebruary 21, 2025 | benzinga.com126,015 Shares in CorMedix Inc. (NASDAQ:CRMD) Purchased by Wingate Wealth Advisors Inc.Wingate Wealth Advisors Inc. acquired a new stake in CorMedix Inc. (NASDAQ:CRMD - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 126,015 shares of the company's stock, valued at approximatFebruary 10, 2025 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) Receives Average Rating of "Buy" from BrokeragesShares of CorMedix Inc. (NASDAQ:CRMD - Get Free Report) have been assigned a consensus recommendation of "Buy" from the six ratings firms that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month price target amoFebruary 10, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Shares Down 3.7% - What's Next?CorMedix (NASDAQ:CRMD) Trading Down 3.7% - Time to Sell?January 29, 2025 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) Position Raised by JPMorgan Chase & Co.JPMorgan Chase & Co. increased its position in shares of CorMedix Inc. (NASDAQ:CRMD - Free Report) by 685.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 194,108 shares of theJanuary 24, 2025 | marketbeat.comD. Boral Capital Reiterates "Buy" Rating for CorMedix (NASDAQ:CRMD)D. Boral Capital reaffirmed a "buy" rating and issued a $15.00 price target on shares of CorMedix in a research report on Wednesday.January 22, 2025 | marketbeat.comCorMedix announces collaboration with WSI PBG for DefenCathJanuary 21, 2025 | markets.businessinsider.comCorMedix (NASDAQ:CRMD) Shares Down 4.2% - Should You Sell?CorMedix (NASDAQ:CRMD) Shares Down 4.2% - Should You Sell?January 17, 2025 | marketbeat.comBarclays PLC Sells 84,122 Shares of CorMedix Inc. (NASDAQ:CRMD)Barclays PLC trimmed its holdings in CorMedix Inc. (NASDAQ:CRMD - Free Report) by 51.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 77,870 shares of the company's stock after selling 84,122 shares durinJanuary 17, 2025 | marketbeat.comCorMedix (NASDAQ:CRMD) Stock Price Up 6.1% - Here's WhyCorMedix (NASDAQ:CRMD) Stock Price Up 6.1% - Here's What HappenedJanuary 16, 2025 | marketbeat.comCorMedix Inc. (NASDAQ:CRMD) Given Consensus Recommendation of "Buy" by BrokeragesCorMedix Inc. (NASDAQ:CRMD - Get Free Report) has earned an average rating of "Buy" from the six research firms that are presently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have issuedJanuary 16, 2025 | marketbeat.comD. Boral Capital Initiates Coverage of CorMedix (CRMD) with Buy RecommendationJanuary 14, 2025 | msn.comCorMedix initiated with a Buy at D. Boral CapitalJanuary 13, 2025 | markets.businessinsider.comD. Boral Capital Initiates Coverage on CorMedix (NASDAQ:CRMD)D. Boral Capital assumed coverage on shares of CorMedix in a report on Monday. They issued a "buy" rating and a $15.00 price target for the company.January 13, 2025 | marketbeat.comRBC Capital Keeps Their Buy Rating on Cormedix (CRMD)January 10, 2025 | markets.businessinsider.comCorMedix (NASDAQ:CRMD) Stock Price Up 2.5% - Should You Buy?CorMedix (NASDAQ:CRMD) Trading Up 2.5% - Time to Buy?January 8, 2025 | marketbeat.comCormedix: Strong Financial Outlook and Strategic Growth Initiatives Support Buy RatingJanuary 8, 2025 | markets.businessinsider.comCorMedix, Inc.: CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business UpdateJanuary 7, 2025 | finanznachrichten.deCormedix Buy Rating: Strong Sales Performance and Expanding Customer Base Signal Positive Growth ProspectsJanuary 7, 2025 | markets.businessinsider.com Remove Ads Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address CRMD Media Mentions By Week CRMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRMD News Sentiment▼0.550.85▲Average Medical News Sentiment CRMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRMD Articles This Week▼233▲CRMD Articles Average Week Remove Ads Get CorMedix News Delivered to You Automatically Sign up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NAMS News HCM News MLTX News IBRX News VCEL News BEAM News MIRM News EWTX News KYMR News CNTA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRMD) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorMedix Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorMedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRMD Stock Free CRMD Stock Alerts